After asthma: redefining airways diseases

ID Pavord, R Beasley, A Agusti, GP Anderson, E Bel… - The Lancet, 2018 - thelancet.com
Executive summary Asthma is responsible for considerable global morbidity and health-care
costs. Substantial progress was made against key outcomes such as hospital admissions …

Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report

VM McDonald, J Fingleton, A Agusti… - European …, 2019 - Eur Respiratory Soc
“Treatable traits” have been proposed as a new paradigm for the management of airway
diseases, particularly complex disease, which aims to apply personalised medicine to each …

Treatable traits: toward precision medicine of chronic airway diseases

A Agusti, E Bel, M Thomas… - European …, 2016 - Eur Respiratory Soc
Asthma and chronic obstructive pulmonary disease (COPD) are two prevalent chronic
airway diseases that have a high personal and social impact. They likely represent a …

Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis

LD Bos, LR Schouten, LA Van Vught, MA Wiewel… - Thorax, 2017 - thorax.bmj.com
Rationale We hypothesised that patients with acute respiratory distress syndrome (ARDS)
can be clustered based on concentrations of plasma biomarkers and that the thereby …

Precision medicine in airway diseases: moving to clinical practice

A Agustí, M Bafadhel, R Beasley, EH Bel… - European …, 2017 - Eur Respiratory Soc
On February 21, 2017, a European Respiratory Society research seminar held in Barcelona
discussed how to best apply precision medicine to chronic airway diseases such as asthma …

Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management

PG Woodruff, A Agusti, N Roche, D Singh, FJ Martinez - The Lancet, 2015 - thelancet.com
Chronic obstructive pulmonary disease (COPD) is a common, complex, and heterogeneous
disorder that is responsible for substantial and growing morbidity, mortality, and health-care …

Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes

JM Anto, J Bousquet, M Akdis, C Auffray, T Keil… - Journal of Allergy and …, 2017 - Elsevier
Asthma, rhinitis, and eczema are complex diseases with multiple genetic and environmental
factors interlinked through IgE-associated and non–IgE-associated mechanisms …

Exhaled molecular fingerprinting in diagnosis and monitoring: validating volatile promises

AW Boots, LD Bos, MP van der Schee… - Trends in molecular …, 2015 - cell.com
Medical diagnosis and phenotyping increasingly incorporate information from complex
biological samples. This has promoted the development and clinical application of non …

The asthma–COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?

ED Bateman, HK Reddel, RN van Zyl-Smit… - The Lancet Respiratory …, 2015 - thelancet.com
Most research of treatments for airways diseases has been restricted to patients who meet
standard definitions of either chronic obstructive pulmonary disease (COPD) or asthma, yet …

[HTML][HTML] Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort

MJ Divo, BR Celli, B Poblador-Plou… - PloS one, 2018 - journals.plos.org
Background Aging is an important risk factor for most chronic diseases. Patients with COPD
develop more comorbidities than non-COPD subjects. We hypothesized that the …